Healthcare Startup Secures $16.5 Million to Automate Medical Equipment Orders
San Francisco, Monday, 12 October 2026.
Ashvin raised $16.5 million in October 2026 following sixfold revenue growth. Its software automates medical equipment processing, handling nearly two-thirds of orders without human intervention.
Capital Injection and Operational Scale
Ashvin AI, based in Cambridge, Massachusetts, announced a $16.5 million investment round on 12 October 2026 [1]. The funding round was led by co-founder Mathew Mammen and includes participation from industry leaders [1][2]. This capital injection follows a period of significant expansion, with the company reporting sixfold revenue growth since emerging from stealth mode in 2025 [1][2].
Platform Capabilities
The platform automates durable medical equipment (DME) workflows, processing referrals from arrival to qualified order in approximately 10 minutes [1]. For some customers, the system achieves up to 64% “No-Touch Orders,” where qualified orders are processed without human intervention [1][2]. This efficiency addresses widespread administrative inefficiencies and labor shortages across the healthcare supply chain [1].
Customer Impact and Efficiency
Bellevue Healthcare, a Pacific Northwest DME provider, reported a 32% reduction in denial rates after implementing Ashvin’s automation platform [1][2]. Joel Gallion, CEO of Bellevue Healthcare, noted that prior to Ashvin, intake teams worked every referral by hand [1]. Now, most orders are cleared without anyone touching them, freeing staff to focus on service provision [1].
Growth Metrics Analysis
The mathematical implication of the revenue growth indicates a substantial scaling operation since the company’s public emergence [1]. Representing the growth multiplier, the calculation 6 reflects the sixfold increase reported by the company [1]. This metric underscores the market demand for automated intake-to-cash solutions in the current economic climate [1].
Strategic Allocation and Industry Context
Ashvin intends to utilize the $16.5 million funding to expand its market reach and develop new capabilities [1]. Specifically, the company is targeting prior authorization processes to further reduce claim issues before orders ship [1][2]. Mathew Mammen emphasized that automating one step of intake does not fix claim errors, necessitating an end-to-end approach [2].
Industry Timeline and Events
The company is scheduled to attend the HME News Business Summit in Louisville, Kentucky, from 12 October 2026 to 14 October 2026 [1]. This event occurs amidst broader industry changes, including updated timelines for the DMEPOS competitive bidding program [2]. Registration for the CMS Round 2028 bidding window is scheduled to open on 1 December 2026 [2].